Literature DB >> 18483640

[Factors associated with survival of patients with tuberculosis in Lima, Peru].

Antonio Bernabé-Ortiz1.   

Abstract

Although in Peru, Control Program of Tuberculosis has been successful in the reduction of incidence, morbidity and mortality, fatal cases are still observed. A longitudinal retrospective study was undertaken in a population on the outskirts of Lima between January 2000 and December 2005. Kaplan-Meier and Cox Regression analysis were used in this study. A total of 425 patients commencing tuberculosis treatment were included, with a case fatality ratio of 4.5%. Factors associated with mortality were: body mass index <18 kg/ m(2) at treatment beginning, HR = 4.89 (95%CI: 1.49 - 16.03) and HIV infection, HR=5.78 (95% CI: 1.11-29.99); whilst education level, HR = 0.28 (95% CI: 0.10 - 0.83) was associated with survival. Amongst this population commencing treatment for tuberculosis, body mass index and HIV infection were associated with an increased risk of death; in contrast, the education level was associated with improving in the survival.

Entities:  

Mesh:

Year:  2008        PMID: 18483640     DOI: /S0716-10182008000300002

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  10 in total

1.  Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.

Authors:  Thomas W McNally; Gilles de Wildt; Graciela Meza; Connie M D Wiskin
Journal:  BMC Health Serv Res       Date:  2019-08-22       Impact factor: 2.655

2.  Family health and conditional cash transfer in Brazil and its effect on tuberculosis mortality.

Authors:  R A de Souza; J S Nery; D Rasella; R A Guimarães Pereira; M L Barreto; L Rodrigues; S M Pereira
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

3.  HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes.

Authors:  Prabhat Jha; Rajesh Kumar; Ajay Khera; Madhulekha Bhattacharya; Paul Arora; Vendhan Gajalakshmi; Prakash Bhatia; Derek Kam; Diego G Bassani; Ashleigh Sullivan; Wilson Suraweera; Catherine McLaughlin; Neeraj Dhingra; Nico Nagelkerke
Journal:  BMJ       Date:  2010-02-23

4.  Modelling the impact of social protection on tuberculosis: the S-PROTECT project.

Authors:  D Boccia; W Rudgard; S Shrestha; K Lönnroth; P Eckhoff; J Golub; M Sanchez; E Maciel; D Rasella; P Shete; D Pedrazzoli; R Houben; S Chang; D Dowdy
Journal:  BMC Public Health       Date:  2018-06-26       Impact factor: 3.295

5.  Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis.

Authors:  Antonio Bernabe-Ortiz; Cesar P Carcamo; Juan F Sanchez; Julia Rios
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

6.  The Poor Survival among Pulmonary Tuberculosis Patients in Chiapas, Mexico: The Case of Los Altos Region.

Authors:  J C Nájera-Ortiz; H J Sánchez-Pérez; H Ochoa-Díaz-López; G Leal-Fernández; A Navarro-Giné
Journal:  Tuberc Res Treat       Date:  2012-05-30

7.  Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors.

Authors:  Kocfa Chung-Delgado; Sonia Guillen-Bravo; Alejandro Revilla-Montag; Antonio Bernabe-Ortiz
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Effect of inpatient and outpatient care on treatment outcome in tuberculosis: a cohort study.

Authors:  Marli S Rocha; Gisele P Oliveira; Valéria Saraceni; Fernanda P Aguiar; Claudia M Coeli; Rejane S Pinheiro
Journal:  Rev Panam Salud Publica       Date:  2018-09-07

9.  Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study.

Authors:  Gustavo E Velásquez; J Peter Cegielski; Megan B Murray; Martin J A Yagui; Luis L Asencios; Jaime N Bayona; César A Bonilla; Hector O Jave; Gloria Yale; Carmen Z Suárez; Eduardo Sanchez; Christian Rojas; Sidney S Atwood; Carmen C Contreras; Janeth Santa Cruz; Sonya S Shin
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

Review 10.  Silver Nanoparticles for the Therapy of Tuberculosis.

Authors:  Alexandru-Flaviu Tăbăran; Cristian Tudor Matea; Teodora Mocan; Alexandra Tăbăran; Marian Mihaiu; Cornel Iancu; Lucian Mocan
Journal:  Int J Nanomedicine       Date:  2020-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.